Skip to content
Balance Sheet · TASI 8020

Malath Cooperative Insurance Co.
Cash and cash equivalents history.

Cash and near-cash balances reported at the reporting date. Explore 15 reported observations from 2023 to 2026, with every value linked to its official evidence.

Coverage2023–202615 source-linked periods
Annual history3annual reporting periods
Interim history12quarterly or year-to-date periods
StatementBalance Sheetas reported by the issuer
Annual series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2025IFRS 17Cash and cash equivalents194.2M SAR
Cash and cash equivalents050M100M150M200M202320242025
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents157.86M SAR
Cash and cash equivalents050M100M150M200M2023202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents121.91M SAR
Cash and cash equivalents050M100M150M200M2023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents132.78M SAR
Cash and cash equivalents050M100M150M200M2023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-30132,78130 September 2026132.78M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20262026-06-30121,90830 June 2026121.91M SARCash and cash equivalentsOfficial p. 4 ↗Open statement →
Q1 20262026-03-31157,85631 March 2026 (Unaudited)157.86M SARCash and cash equivalentsNote 4Signed copy p. 4 ↗Saudi Exchange filing ↗Open statement →
FY 20252025-12-31194,2042025-12-31194.2M SARCash and cash equivalentsNote 4Official p. 2 ↗Open statement →
9M / Q3 20252025-09-30145,77330 September 2025 · SAR’000145.77M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20252025-06-30193,71430 June 2025 · SAR’000193.71M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20252025-03-31171,21731 March 2025 · SAR’000171.22M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
FY 20242024-12-31Comparative figures in an audited report172,9752024-12-31172.98M SARCash and cash equivalentsNote 4Official p. 2 ↗Open statement →
9M / Q3 20242024-09-30150,75530 September 2024 · SAR’000150.76M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
H1 / Q2 20242024-06-30102,10030 June 2024 · SAR’000102.1M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
Q1 20242024-03-3193,32131 March 2024 · SAR’00093.32M SARCash and cash equivalentsNote 4Official p. 4 ↗Open statement →
FY 20232023-12-31Comparative figures in an audited report110,5712023-12-31110.57M SARCash and cash equivalentsNote 4Official p. 11 ↗Open statement →
9M / Q3 20232023-09-301393352023-09-30139.34M SARCash and cash equivalentsNote 5Official p. 4 ↗Open statement →
H1 / Q2 20232023-06-301101502023-06-30110.15M SARCash and cash equivalentsNote 5Official p. 4 ↗Open statement →
Q1 20232023-03-31896532023-03-3189.65M SARCash and cash equivalentsNote 5Official p. 4 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

ملاذ للتأمين — Cash and cash equivalents

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.